Provensis Drug Patent Portfolio
Provensis owns 1 orange book drug protected by 16 US patents Given below is the list of Provensis's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9480652 | Aerosol valve | 12 May, 2032 | Active |
| US7814943 | Apparatus and method for dispensing foam | 19 Nov, 2027 | Active |
| US7731986 | Therapeutic foam | 17 Nov, 2024 | Expired |
| US8122917 | Apparatus and method for dispensing foam | 09 Sep, 2024 | Expired |
| US6846412 | Combination filter assembly | 19 Jul, 2022 | Expired |
| US6572873 | Generation of therapeutic microfoam | 26 May, 2020 | Expired |
| US6942165 | Generation of therapeutic microfoam | 26 May, 2020 | Expired |
| US7025290 | Generation of therapeutic microfoam | 26 May, 2020 | Expired |
| US7357336 | Generation of therapeutic microfoam | 26 May, 2020 | Expired |
| US7604185 | Generation of therapeutic microfoam | 26 May, 2020 | Expired |
| US7842282 | Generation of therapeutic microfoam | 26 May, 2020 | Expired |
| US7842283 | Generation of therapeutic microfoam | 26 May, 2020 | Expired |
| US8323677 | Therapeutic foam | 26 May, 2020 | Expired |
| US8734833 | Therapeutic foam | 26 May, 2020 | Expired |
| USRE40640 | Injectable microfoam containing a sclerosing agent | 14 Oct, 2016 | Expired |
| USRE38919 | Injectable microfoam containing a sclerosing agent | 14 Oct, 2014 | Expired |
Latest Legal Activities on Provensis's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Provensis.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Maintenance Fee Reminder Mailed
Critical
| 24 Jun, 2024 | US9480652 |
|
Expire Patent
Critical
| 01 Apr, 2024 | US8122917 |
|
Maintenance Fee Reminder Mailed
Critical
| 16 Oct, 2023 | US8122917 |
|
Interim Patent Term Extension Granted
Critical
| 28 Feb, 2023 | US7357336 |
|
Expire Patent
Critical
| 04 Jul, 2022 | US8734833 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 18 May, 2022 | US7842282 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 18 May, 2022 | US7842283 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 06 Apr, 2022 | US7814943 |
|
Interim Patent Term Extension Granted
Critical
| 07 Mar, 2022 | US7357336 |
|
Maintenance Fee Reminder Mailed
Critical
| 17 Jan, 2022 | US8734833 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 24 Nov, 2021 | US7731986 |
|
Expire Patent
Critical
| 22 Nov, 2021 | US7604185 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 09 Sep, 2021 | US7731986 |
|
Email Notification
Critical
| 09 Sep, 2021 | US7731986 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 07 Sep, 2021 | US7357336 |
Provensis's Family Patents
Provensis drugs have patent protection in a total of 30 countries. It's US patent count contributes only to 16.7% of its total global patent coverage. Click
below to unlock the full patent family tree.
Provensis Drug List
Given below is the complete list of Provensis's drugs and the patents protecting them.
1. Varithena
Varithena is protected by 16 patents, out of which 14 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9480652 | Aerosol valve |
12 May, 2032
(7 years from now)
| Active |
| US7814943 | Apparatus and method for dispensing foam |
19 Nov, 2027
(2 years from now)
| Active |
| US7731986 | Therapeutic foam |
17 Nov, 2024
(2 months ago)
| Expired |
| US8122917 | Apparatus and method for dispensing foam |
09 Sep, 2024
(4 months ago)
| Expired |
| US6846412 | Combination filter assembly |
19 Jul, 2022
(2 years ago)
| Expired |
| US6572873 | Generation of therapeutic microfoam |
26 May, 2020
(4 years ago)
| Expired |
| US6942165 | Generation of therapeutic microfoam |
26 May, 2020
(4 years ago)
| Expired |
| US7025290 | Generation of therapeutic microfoam |
26 May, 2020
(4 years ago)
| Expired |
| US7357336 | Generation of therapeutic microfoam |
26 May, 2020
(4 years ago)
| Expired |
| US7604185 | Generation of therapeutic microfoam |
26 May, 2020
(4 years ago)
| Expired |
| US7842282 | Generation of therapeutic microfoam |
26 May, 2020
(4 years ago)
| Expired |
| US7842283 | Generation of therapeutic microfoam |
26 May, 2020
(4 years ago)
| Expired |
| US8323677 | Therapeutic foam |
26 May, 2020
(4 years ago)
| Expired |
| US8734833 | Therapeutic foam |
26 May, 2020
(4 years ago)
| Expired |
| USRE40640 | Injectable microfoam containing a sclerosing agent |
14 Oct, 2016
(8 years ago)
| Expired |
| USRE38919 | Injectable microfoam containing a sclerosing agent |
14 Oct, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Varithena's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List